Prevention of Diabetes Mellitus Development in Women Who Had Already Experienced A Gestational Diabetes
Type 2 Diabetes Mellitus
About this trial
This is an interventional prevention trial for Type 2 Diabetes Mellitus focused on measuring metformin, gestational diabetes, lifestyle
Eligibility Criteria
Inclusion Criteria: GDM - experienced during pregnancy (diagnosis of GDM according to WHO-criteria) Breast-feeding of the newborn finished (lactation finished) Actual BMI >= 25 kg/ m2 Written consent for participation in the study A hitherto prevailing good cooperation with the patient Exclusion Criteria: Cholestasis during the past pregnancy Any hepatic diseases in the past (viral hepatitis, toxic hepatic damage,jaundice of unknown etiology) Serum ASPAT and/or ALAT level exceeding more than twice normal laboratory values Pregnancy planned during the coming two years Presence of contradictions for metformin administration according to demands of the Drug Admission Committee in Poland